REPH insider filings

Recro Pharma, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-03-17. Screen REPH transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for REPH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Recro Pharma, Inc.

FiledFormInsiderReported transactionsSource
2022-03-174ENLOE J DAVID JR — Chief Executive Officer, DirectorPurchase (P): 512 @ $1.96EDGAR
2022-02-174ENLOE J DAVID JR — Chief Executive Officer, DirectorPurchase (P): 571 @ $1.77EDGAR
2022-02-044Lake Ryan David — Chief Financial OfficerTax withholding (F): 1,021 @ $1.54EDGAR
2022-02-024Lake Ryan David — Chief Financial OfficerTax withholding (F): 1,419 @ $1.54EDGAR
2022-01-244Lake Ryan David — Chief Financial OfficerGrant/award (A): 39,604 · Grant/award (A): 169,697 @ $0 · Grant/award (A): 247,788 (derivative) @ $0EDGAR
2022-01-244ENLOE J DAVID JR — Chief Executive Officer, DirectorGrant/award (A): 66,007 · Grant/award (A): 303,030 @ $0 · Grant/award (A): 442,478 (derivative) @ $0EDGAR
2022-01-194Lake Ryan David — Chief Financial OfficerTax withholding (F): 1,094 @ $1.65EDGAR
2022-01-194ENLOE J DAVID JR — Chief Executive Officer, DirectorPurchase (P): 602 @ $1.68EDGAR
2022-01-044Lake Ryan David — Chief Financial OfficerTax withholding (F): 28,730 @ $1.71 · Tax withholding (F): 979 @ $1.74EDGAR
2021-12-234AWM Investment Company, Inc. — 10% ownerSale (S): 99,398 @ $1.55EDGAR
2021-12-204AWM Investment Company, Inc. — 10% ownerSale (S): 50,000 @ $1.61EDGAR
2021-12-174Lake Ryan David — Chief Financial OfficerTax withholding (F): 5,690 @ $1.61EDGAR
2021-12-174ENLOE J DAVID JR — Chief Executive Officer, DirectorPurchase (P): 617 @ $1.61EDGAR
2021-12-154AWM Investment Company, Inc. — 10% ownerSale (S): 20,000 @ $1.63 · Sale (S): 10,602 @ $1.57 · Sale (S): 20,000 @ $1.63EDGAR
2021-11-194Miller James Charles — DirectorPurchase (P): 1,000 @ $1.69EDGAR
2021-11-164Lake Ryan David — Chief Financial OfficerPurchase (P): 1,162 @ $1.65 · Purchase (P): 50 @ $1.62EDGAR
2021-11-164ENLOE J DAVID JR — Chief Executive Officer, DirectorPurchase (P): 1,725 @ $1.68EDGAR
2021-07-134Lake Ryan David — Chief Financial OfficerTax withholding (F): 5,172 @ $1.96EDGAR
2021-06-214Parks Laura L. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-06-144AWM Investment Company, Inc. — 10% ownerSale (S): 150,000 @ $2.23 · Sale (S): 50,000 @ $2.16 · Sale (S): 266,667 @ $2.20EDGAR
2021-06-084Lake Ryan David — Chief Financial OfficerOption exercise (M): 2,500 · Tax withholding (F): 719 @ $2.30 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2021-05-174/AWeisman Wayne — DirectorGrant/award (A): 38,012 (derivative) @ $0EDGAR
2021-05-174/ACHURCHILL WINSTON J — DirectorGrant/award (A): 38,012 (derivative) @ $0EDGAR
2021-05-174/AMiller James Charles — DirectorGrant/award (A): 38,012 (derivative) @ $0EDGAR
2021-05-174/AReasons Bryan M. — DirectorGrant/award (A): 38,012 (derivative) @ $0EDGAR
2021-05-174/ABerelowitz Michael — DirectorGrant/award (A): 38,012 (derivative) @ $0EDGAR
2021-05-174/AAshton William — DirectorGrant/award (A): 38,012 (derivative) @ $0EDGAR
2021-05-174/AHENWOOD GERALDINE — DirectorGrant/award (A): 38,012 (derivative) @ $0EDGAR
2021-04-224Miller James Charles — DirectorGrant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0EDGAR
2021-04-224Weisman Wayne — DirectorGrant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0EDGAR
2021-04-224CHURCHILL WINSTON J — DirectorGrant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0EDGAR
2021-04-224Reasons Bryan M. — DirectorGrant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0EDGAR
2021-04-224Berelowitz Michael — DirectorGrant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0EDGAR
2021-04-224Ashton William — DirectorGrant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0EDGAR
2021-04-224HENWOOD GERALDINE — DirectorGrant/award (A): 26,923 @ $0 · Grant/award (A): 38,012 (derivative) @ $0EDGAR
2021-04-154HENWOOD GERALDINE — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2021-04-124Lake Ryan David — Chief Financial OfficerTax withholding (F): 5,172 @ $3.24EDGAR
2021-02-124Miller James Charles — DirectorOption exercise (M): 20,000 (derivative) @ $0EDGAR
2021-02-124Lake Ryan David — Chief Financial OfficerTax withholding (F): 1,075 @ $3.74EDGAR
2021-01-204Lake Ryan David — Chief Financial OfficerTax withholding (F): 1,352 @ $3.03EDGAR
2021-01-204HENWOOD GERALDINE — DirectorOption exercise (M): 5,000 · Tax withholding (F): 6,816 @ $3.03 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2021-01-124Lake Ryan David — Chief Financial OfficerGrant/award (A): 36,000 @ $0 · Grant/award (A): 200,000 @ $0 · Grant/award (A): 30,000 · Tax withholding (F): 12,610 @ $2.99EDGAR
2021-01-054Lake Ryan David — Chief Financial OfficerTax withholding (F): 1,210 @ $3.09EDGAR
2021-01-054HENWOOD GERALDINE — DirectorTax withholding (F): 5,599 @ $3.09EDGAR
2020-12-284SCP Vitalife Partners (Israel) II, L.P. — 10% ownerSale (S): 18,830 @ $3.17EDGAR
2020-12-284SCP Vitalife Partners II LP — 10% ownerSale (S): 56,375 @ $3.17EDGAR
2020-12-224SCP Vitalife Partners (Israel) II, L.P. — 10% ownerSale (S): 6,208 @ $3.03EDGAR
2020-12-224SCP Vitalife Partners II LP — 10% ownerSale (S): 18,587 @ $3.03EDGAR
2020-12-184Lake Ryan David — Chief Financial OfficerGrant/award (A): 79,208 @ $0 · Grant/award (A): 116,505 (derivative) @ $0EDGAR
2020-12-184ENLOE J DAVID JR — Chief Executive Officer, DirectorGrant/award (A): 19,802 @ $0 · Grant/award (A): 132,013 @ $0 · Grant/award (A): 194,175 (derivative) @ $0EDGAR

Recent 8-K events — Recro Pharma, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-04-088-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-158-K8.01 — Other EventsEDGAR
2024-02-288-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-288-K1.01 — Entry into a Material Definitive Agreement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-088-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-09-208-K?
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-288-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2023-08-238-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-08-148-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-268-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=REPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs